Anticoagulants don’t decrease survival or raise LGB risk
From the Medical Editors of Cleveland Clinic’s Research Notes: Kidney Transplant
Innovation and expansion improve access to care
Risk aversion may be a factor in reduced transplant volumes
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Improving a mainstay of renal transplant immunosuppression
Proliferation is linked to heightened risk of acute graft rejection